NDC 71335-1731 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-1731

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1731-03 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-0)Apr 4, 2024
71335-1731-130 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-1)Jan 28, 2021
71335-1731-210 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-2)Jan 5, 2021
71335-1731-35 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-3)Dec 29, 2020
71335-1731-44 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-4)May 24, 2021
71335-1731-56 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-5)Dec 28, 2020
71335-1731-614 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-6)Apr 4, 2024
71335-1731-760 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-7)Apr 4, 2024
71335-1731-812 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-8)Apr 4, 2024
71335-1731-990 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-9)Apr 4, 2024

Other Ondansetron products